FertilityAnswer Bot bot includes 150 questions and answers from Ovum Health’s content library of 18,000 user-generated questions. Credit: everything possible/Shutterstock

Fertility solutions provider Ovum Health has joined forces with IBM Watson to enhance appointment management and access to patient information.

Alice Crisci, a healthcare activist, cancer survivor, mother, and founder of MedAnswers and its telemedicine spinout, Ovum Health is aiming to increase family-building solutions, including pre-pregnancy, prenatal, and postnatal healthcare through digital services.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

According to Ovum Health it needed an artificial intelligence (AI) solution to advance its digital offering and turned to the IBM Ecosystem and IBM Watson Assistant.

The partnership between Ovum Health and IBM Watson will utilise each other’s tech and build an international digital service with embed Watsonx Assistant for their mobile app and website called FertilityAnswer Bot. The chat bot will streamline fertility questions and answers to enhance the patients experience. It also has a scheduling feature to allow patients to book medical appointments at the click of a button.

The IBM-powered bot includes 150 questions and answers from Ovum Health’s content library of 18,000 user-generated questions. Backed by clinically validated responses from reproductive experts. Currently there are over 67,000 registered users of the FertilityAnswer Bot across both iOS and Android systems.

IBM will also help Ovum Health identify the return on investment (ROI) of incorporating IBM’s AI technology into their products and services.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

There have been recent technology and device developments in the reproductive health market such as sperm diagnostic systems and other in vitro fertilization (IVF) treatments.

According to GlobalData, the global market for reproductive health devices is forecast to approach sales of $3.7bn by 2030.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact